Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[In vitro drug sensitivity test].

H Nakano, N Saijo, Y Sasaki

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Stable transformation of Eustoma grandiflorum by particle bombardment.

    Plant cell reports·2019
    Same author

    Erythematous lesion with peripheral purpura on the face.

    Clinical and experimental dermatology·2018
    Same author

    The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor-naïve patients with chronic HCV genotype 1b infection in a real-world cohort.

    Journal of viral hepatitis·2017
    Same author

    Development of non-invasive method for assessment of hepatic steatosis.

    Ultrasonics·2016
    Same author

    L-type Ca²⁺ channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory.

    Molecular psychiatry·2015
    Same author

    Establishment of educational program for multiorgan procurement from deceased donors.

    Transplantation proceedings·2014

    The MINI-hybrid assay offers a more efficient method for predicting patient anticancer drug sensitivity and testing new cancer treatments. This assay demonstrates high success rates, requires fewer cells, and provides faster results compared to traditional methods.

    Area of Science:

    • Oncology
    • Pharmacology
    • Biotechnology

    Context:

    • The Human Tumor Clonogenic Assay (HTCA) is valuable for predicting patient drug sensitivity and preclinical testing of anticancer agents.
    • HTCA faces challenges including low success rates, high cell number requirements, and lengthy evaluation times.

    Purpose:

    • To introduce and evaluate the MINI-hybrid assay as an improved alternative to HTCA for cancer drug sensitivity testing.
    • To address the limitations of HTCA by developing a more efficient and reliable assay.

    Summary:

    • The MINI-hybrid assay achieved a 95.6% evaluability rate across 23 tumors.
    • Results from the MINI-hybrid assay correlated well with those from HTCA for drug sensitivity testing in cell lines.
    • The assay requires fewer cells, offers rapid quantitation, and has a short 5-day duration.

    Related Experiment Videos

    Impact:

    • The MINI-hybrid assay is highly applicable for chemosensitivity testing of human tumors.
    • It provides a more efficient and reliable method for personalized cancer treatment strategies.
    • Facilitates faster development and preclinical testing of novel antineoplastic agents.